Production (Stage)
aTyr Pharma, Inc.
ATYR
$3.75
-$0.05-1.32%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -63.41M | -64.02M | -63.82M | -57.90M | -53.93M |
Total Depreciation and Amortization | 1.15M | 1.54M | 1.95M | 2.55M | 2.76M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 1.00M | 282.00K | -162.00K | -618.00K | -851.00K |
Change in Net Operating Assets | -903.00K | -6.92M | -5.02M | -7.49M | -2.99M |
Cash from Operations | -62.16M | -69.12M | -67.05M | -63.45M | -55.01M |
Capital Expenditure | -48.00K | -65.00K | -57.00K | -599.00K | -2.99M |
Sale of Property, Plant, and Equipment | 7.00K | 7.00K | 0.00 | 0.00 | 15.00K |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 14.21M | 17.29M | 41.19M | 28.17M | 19.66M |
Cash from Investing | 14.17M | 17.23M | 41.14M | 27.57M | 16.69M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -507.00K | -497.00K | -484.00K | -467.00K | -449.00K |
Issuance of Common Stock | 51.27M | 40.36M | 27.54M | 30.31M | 24.91M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 50.76M | 39.86M | 27.06M | 29.85M | 24.46M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 2.77M | -12.02M | 1.15M | -6.03M | -13.86M |